NewsDesk  @infectiousdiseasenews The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe...

NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease...

NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for the treatment...

NewsDesk  @infectiousdiseasenews On Wednesday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld for the pre-exposure prophylaxis of COVID-19...

NewsDesk  @infectiousdiseasenews Lyme disease cases are becoming more frequent and widespread. Currently, it affects almost half a million people nationwide each year. Lyme disease is caused by a bacterium, Borelliella...

By NewsDesk  @bactiman63  AMIVAS Ireland Ltd., specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today the European Commission has granted approval...

The U.S. Food and Drug Administration approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant...

By NewsDesk  @bactiman63  An analysis by the Center for Combating Corruption conclude in a new study that 4 out of 10 people purchased drugs that are ineffective and absent in modern treatment standards....

By NewsDesk  @bactiman63 Researchers this week published interim results in The New England Journal of Medicine from a Phase 3 study of the COVID-19 monoclonal antibody treatment sotrovimab, sponsored...

NewsDesk @bactiman63 Merck announced voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely...